A silent killer, Pulmonary Embolism (PE) is the third most common cause of death from cardiovascular disease, just after heart attack and stroke. With rapid diagnosis and treatment, survival rates can be significantly improved.
As a member of the Pulmonary Embolism Response Team (PERT) Consortium, Columbia is in the vanguard of treating pulmonary embolism with a rapid response, multidisciplinary team. The PERT Consortium aims to guide and influence PE care and research in institutions across the U.S. and to become the driving force behind increased survival rates and future treatment.
Koji Takeda, MD, PhD, surgical director of our Pulmonary Thromboendarterectomy Program, is one of the few surgeons in the country who routinely addresses chronic thromboembolic pulmonary hypertension (CTEPH) with pulmonary thromboendarterectomy (PTE). This complex surgical procedure removes chronic clots from the pulmonary arteries and can save lives.
To contact the Pulmonary Embolism Response Team, call (212) 305-5156.